Mr. Roth previously served as Director of New Technology & Intellectual Property at Icon Interventional Systems, Inc. where he led the development of the MoRe proprietary alloy. Mr. Roth has over 20 years of Product Development experience, is the recipient of 24 patents, and is admitted to both the State Bar of Georgia and New Jersey. He began his medical device career with Micro Therapeutics, where he developed the first liquid embolic system (Onyx) for the treatment of intracranial aneurysms, designed and developed micro catheters and compliant balloon systems for stent delivery, and designed and developed a self-expanding thin film stent system for the exclusion of vascular malformations. Following that he spent 7.5 years at the Cordis Corporation, a Johnson & Johnson Company as Manager of New Product Development. In this position, he managed cross functional and multi-site project teams, resulting in the successful launch of two new product families within a 1-year time frame, and approximately $125 million in new annual revenue. Mr. Roth holds JD from Rutgers School of Law Newark; MS in Biomedical Engineering from University of Tennessee Health Science Center School of Biomedical Engineering and BS in Mechanical Engineering from Polytechnic University